In patients with inflammatory bowel disease (IBD), besides the typical presence of intestinal macrophages, there is an additional reactive macrophage population along with elevated levels of monocyte chemoattractant protein 1 detected in the mucosa [9]. Here, CCL2 is linked to inflammatory bowel disease.